Provepharm Inc. recalls Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm…

Recall date

November 22, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0150-2025

FDA classification

Class II

Brand / firm

Provepharm Inc.

Sold / distributed

Nationwide within the United States

Why it was recalled

Discoloration

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05